A Phase 1, Open-Label, 4-Way Crossover Regional Drug Absorption Study to Assess the Bioavailability of ASP015K in Healthy Subjects

Trial Profile

A Phase 1, Open-Label, 4-Way Crossover Regional Drug Absorption Study to Assess the Bioavailability of ASP015K in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2011

At a glance

  • Drugs Peficitinib (Primary) ; Peficitinib (Primary)
  • Indications Plaque psoriasis; Transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top